Phathom Pharmaceuticals, Inc. PHAT Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s accrued liabilities, current?
- Phathom Pharmaceuticals, Inc. (PHAT) reported accrued liabilities, current of $83.32M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s accrued liabilities, current changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s accrued liabilities, current increased by 93.6% year-over-year, from $43.03M to $83.32M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s accrued liabilities, current has grown at a 53.3% compound annual growth rate (CAGR), from $10.61M to $89.83M.